NASDAQ:PETS PetMed Express (PETS) Stock Price, News & Analysis $2.65 +0.14 (+5.58%) Closing price 04:00 PM EasternExtended Trading$2.64 -0.01 (-0.42%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About PetMed Express Stock (NASDAQ:PETS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PetMed Express alerts:Sign Up Key Stats Today's Range$2.46▼$2.6550-Day Range$2.42▼$3.2152-Week Range$2.42▼$6.85Volume110,301 shsAverage Volume91,136 shsMarket Capitalization$55.70 millionP/E RatioN/ADividend YieldN/APrice Target$3.20Consensus RatingSell Company Overview PetMed Express, Inc. operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations. Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications. The company launched its initial public offering in 2000 and has since developed an in‐house team of veterinarians and pharmacy professionals to review prescriptions and provide customer support. With a multi‐channel approach that includes online ordering, telephone service and direct mail catalogs, PetMed Express seeks to simplify the process of obtaining essential pet health products. PetMed Express primarily serves customers across the United States, with select offerings available in Canada. Its operations center around a fulfillment facility in Florida, supported by a network of third‐party carriers for nationwide delivery. The company is led by its founder and Chief Executive Officer, Marc Puleo, who oversees strategy and business development alongside a management team experienced in pharmaceutical distribution and e-commerce. PetMed Express continues to focus on expanding its product portfolio, enhancing digital capabilities and maintaining compliance with regulatory standards in veterinary pharmacy.AI Generated. May Contain Errors. Read More PetMed Express Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScorePETS MarketRank™: PetMed Express scored higher than 39% of companies evaluated by MarketBeat, and ranked 155th out of 214 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingSell Consensus RatingPetMed Express has received a consensus rating of Sell. The company's average rating score is 1.33, and is based on no buy ratings, 1 hold rating, and 2 sell ratings.Upside PotentialPetMed Express has a consensus price target of $3.20, representing about 21.2% upside from its current price of $2.64.Amount of Analyst CoveragePetMed Express has only been the subject of 2 research reports in the past 90 days.Read more about PetMed Express' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-84.21% Earnings GrowthEarnings for PetMed Express are expected to decrease by -84.21% in the coming year, from $0.19 to $0.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PetMed Express is -8.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PetMed Express is -8.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPetMed Express has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about PetMed Express' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.64% of the float of PetMed Express has been sold short.Short Interest Ratio / Days to CoverPetMed Express has a short interest ratio ("days to cover") of 13.8, which indicates bearish sentiment.Change versus previous monthShort interest in PetMed Express has recently decreased by 7.25%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldPetMed Express does not currently pay a dividend.Dividend GrowthPetMed Express does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of PetMed Express is 9,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, PetMed Express will have a dividend payout ratio of 3,000.00% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend.Read more about PetMed Express' dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted12.64% of the float of PetMed Express has been sold short.Short Interest Ratio / Days to CoverPetMed Express has a short interest ratio ("days to cover") of 13.8, which indicates bearish sentiment.Change versus previous monthShort interest in PetMed Express has recently decreased by 7.25%, indicating that investor sentiment is improving significantly. News and Social Media1.8 / 5News Sentiment0.27 News SentimentPetMed Express has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Retail/Wholesale companies.News Coverage This WeekMarketBeat has tracked 8 news articles for PetMed Express this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for PETS on MarketBeat in the last 30 days. This is a decrease of -55% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, PetMed Express insiders have bought more of their company's stock than they have sold. Specifically, they have bought $699,592.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.10% of the stock of PetMed Express is held by insiders.Percentage Held by Institutions73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PetMed Express' insider trading history. Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PETS Stock News HeadlinesPetMed Express appoints James LaCamp to board of directorsOctober 21 at 2:05 AM | msn.comPetMed Express Appoints James LaCamp as New Board Member and Chair of Audit CommitteeOctober 20 at 8:50 AM | quiverquant.comQINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.October 21 at 2:00 AM | Traders Agency (Ad)PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee ChairOctober 20 at 8:30 AM | globenewswire.comPETMED REMINDER: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of StockholdersOctober 15, 2025 | globenewswire.comPetMed Express, Inc.: PetMeds Files Form 10-K for Fiscal 2025October 15, 2025 | finanznachrichten.dePetMed Express, Inc. Files Annual Report on Form 10-K for Fiscal Year 2025, Reports Financial Highlights and Future Reporting PlansOctober 14, 2025 | quiverquant.comQPetMeds® Files Form 10-K for Fiscal 2025October 14, 2025 | globenewswire.comSee More Headlines PETS Stock Analysis - Frequently Asked Questions How have PETS shares performed this year? PetMed Express' stock was trading at $4.82 on January 1st, 2025. Since then, PETS stock has decreased by 45.2% and is now trading at $2.64. How were PetMed Express' earnings last quarter? PetMed Express, Inc. (NASDAQ:PETS) posted its quarterly earnings results on Tuesday, October, 14th. The company reported ($0.56) EPS for the quarter, missing analysts' consensus estimates of $0.04 by $0.60. The firm had revenue of $46.47 million for the quarter. PetMed Express had a negative trailing twelve-month return on equity of 6.76% and a negative net margin of 2.76%. How do I buy shares of PetMed Express? Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PetMed Express own? Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Meta Platforms (META), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Walt Disney (DIS), Ford Motor (F) and PayPal (PYPL). Company Calendar Last Earnings10/14/2025Today10/21/2025Next Earnings (Estimated)11/05/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorRetail/Wholesale Industry INTERNET COMMERCE Sub-IndustryInternet Retail Current SymbolNASDAQ:PETS CIK1040130 Webwww.1800petmeds.com Phone(561) 526-4444Fax561-526-4445Employees210Year Founded1996Price Target and Rating Average Price Target for PetMed Express$3.20 High Price Target$3.20 Low Price Target$3.20 Potential Upside/Downside+22.1%Consensus RatingSell Rating Score (0-4)1.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.01 Trailing P/E RatioN/A Forward P/E Ratio13.79 P/E GrowthN/ANet Income-$6.27 million Net Margins-2.76% Pretax Margin-0.26% Return on Equity-6.76% Return on Assets-4.24% Debt Debt-to-Equity RatioN/A Current Ratio1.26 Quick Ratio1.00 Sales & Book Value Annual Sales$226.97 million Price / Sales0.24 Cash Flow$0.04 per share Price / Cash Flow67.51 Book Value$4.12 per share Price / Book0.64Miscellaneous Outstanding Shares21,016,000Free Float20,785,000Market Cap$55.06 million OptionableOptionable Beta0.73 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:PETS) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetMed Express, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PetMed Express With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.